7/16/2013 9:56:33 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ADVISORY, July 16, 2013 (GLOBE NEWSWIRE) --What: Esperion Therapeutics, Inc. [ESPR], a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, will visit the NASDAQ MarketSite in Times Square in celebration of its recent IPO and its return to the NASDAQ Stock Market as a publicly traded company which occurred on June 26.
Help employers find you! Check out all the jobs and post your resume.
comments powered by